Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
REGN | REGENERON PHARMACEUTICALS, INC. | EVP General Counsel and Secret | $42.6 M | -$4.76 M | -10.1% | Jun 24, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|